Login / Signup

Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a.

Franziska RinkerCorinna M BremerKathrin SchröderSteffen B WiegandBirgit BremerMichael P MannsAnke R M KraftHeiner WedemeyerLei YangVedran PavlovicCynthia WatWolfram H GerlichDieter GlebeMarkus Cornberg
Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Hepatitis B surface protein levels differ by HBV genotype. However, quantification of HBs proteins has no advantage over the already established HBsAg assays to predict response to peginterferon alfa-2a therapy in HBeAg-positive patients.
Keyphrases